Unable to display view head.php file not found.
 
 

Steven A. Rothman, MD - AFib Treatment: General Population - Figure 25

TTR = Risk Protection

This Figure illustrates a very simple concept: in this retrospective study of >6,000 patients in the United Kingdom, freedom from risk of stroke is greatly increased for patients who are kept within the INR 2–3 therapeutic window between 70% and 100% of the time.  This benefit decreases dramatically, however, when the %-time in therapeutic range (TTR) decreases to <70%.[75]

Rothman SA. Am J Med 2013; 126: 00-00.

Complete references for all slides

References

[75] Morgan CL, McEwan P, Tukiendorf A, Robinson PA, Clemens A, Plumb JM. Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control. Thromb Res. 2009;124:37-41.

Unable to display view foot.php file not found.